The Challenges And Opportunities Of Antibody Therapies

Antibody-based therapeutics, which are comprised of antibodies that target and attack specific antigens, have dramatically risen in popularity. Antibody-based oncology therapies and COVID-19 treatments are in particularly high demand.

This leaves suppliers with the challenging task of quickly developing and manufacturing antibody therapies at scale. In this article, we break down the hurdles of antibody development and manufacturing and discuss exciting antibody developments in the near future.

Key topics covered:

• Significant Complexities of Antibody Development
• Challenges in mAb Manufacturing
• Antibody Therapies on the Horizon